0001042167-21-000049.txt : 20210621 0001042167-21-000049.hdr.sgml : 20210621 20210621125137 ACCESSION NUMBER: 0001042167-21-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FISCH HARRY CENTRAL INDEX KEY: 0001688984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13602 FILM NUMBER: 211029264 MAIL ADDRESS: STREET 1: 515 N. STATE STREET, SUITE 2225 STREET 2: C/O THE FEMALE HEALTH COMPANY CITY: CHICAGO STATE: IL ZIP: 60654 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERU INC. CENTRAL INDEX KEY: 0000863894 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 391144397 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 48 NW 25TH STREET STREET 2: SUITE 102 CITY: MIAMI STATE: FL ZIP: 33127 BUSINESS PHONE: 3125959123 MAIL ADDRESS: STREET 1: 48 NW 25TH STREET STREET 2: SUITE 102 CITY: MIAMI STATE: FL ZIP: 33127 FORMER COMPANY: FORMER CONFORMED NAME: FEMALE HEALTH CO DATE OF NAME CHANGE: 19960205 FORMER COMPANY: FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-06-16 0 0000863894 VERU INC. VERU 0001688984 FISCH HARRY 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 1 0 1 0 Common Stock 2021-06-16 4 S 0 100000 8.353 D 764025 D Common Stock 7239096 I Footnote 3 The price reported above is the weighted average transaction price. The range of prices for such transaction is $8.23 to $8.48. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. Includes 541,144 shares held jointly by the reporting person and his spouse. The shares are held by K&H Fisch Family Partners, LLC, of which the reporting person is the sole manager. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose. /s/ Phil M. Greenberg, via Power of Attorney 2021-06-18